The Role of Azithromycin in Patients with Cystic Fibrosis

被引：38
|
作者：
Yousef, Abdullah A. [1 ,2 ,3 ]
Jaffe, Adam [2 ,3 ]
机构：
[1] King Faisal Univ, Dept Paediat, Dammam, Saudi Arabia
[2] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia
[3] Sydney Childrens Hosp, Dept Resp Med, Randwick, NSW 2031, Australia
来源：
PAEDIATRIC RESPIRATORY REVIEWS | 2010年 / 11卷 / 02期
关键词：
macrolides; cystic fibrosis; inflammation; azithromycin; BRONCHIAL EPITHELIAL-CELLS; 14-MEMBERED RING MACROLIDES; LONG-TERM AZITHROMYCIN; NECROSIS-FACTOR-ALPHA; PSEUDOMONAS-AERUGINOSA; DIFFUSE PANBRONCHIOLITIS; IN-VITRO; CYTOKINE PRODUCTION; CONTROLLED-TRIAL; ERYTHROMYCIN;
D O I：
10.1016/j.prrv.2009.12.003
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Interest in azithromycin in the management of patients with cystic fibrosis has grown over the last decade. Uniquely this drug has both antibacterial and immune modulating effects which appear to be the reason for its clinical benefit as proven in several well designed clinical studies. In this review we discuss the proposed mechanisms of action of azithromycin and review the evidence for its clinical effectiveness and safety in cystic fibrosis. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：108 / 114
页数：7
相关论文
共 50 条
  • [1] Azithromycin use in patients with cystic fibrosis
    N. Principi
    F. Blasi
    S. Esposito
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 1071 - 1079
  • [2] Azithromycin use in patients with cystic fibrosis
    Principi, N.
    Blasi, F.
    Esposito, S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (06) : 1071 - 1079
  • [3] Azithromycin for cystic fibrosis
    Southern, KW
    Barker, PM
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (05) : 834 - 838
  • [4] Azithromycin and cystic fibrosis
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (08) : 739 - 739
  • [5] Azithromycin in cystic fibrosis
    Kastelik, JA
    Peckham, DG
    Conway, S
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (04) : 771 - 771
  • [6] Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis
    Saiman, L
    Mayer-Hamblett, N
    Campbell, P
    Marshall, BC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) : 1008 - 1012
  • [7] Long term azithromycin therapy in patients with cystic fibrosis
    Emiralioglu, Nagehan
    Ozturk, Zeynelabidin
    Yalcin, Ebru
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    TURKISH JOURNAL OF PEDIATRICS, 2016, 58 (01) : 34 - 40
  • [8] Daily versus weekly azithromycin in cystic fibrosis patients
    McCormack, J.
    Bell, S.
    Senini, S.
    Waimsley, K.
    Patel, K.
    Wainwright, C.
    Serisier, D.
    Harris, M.
    Bowler, S.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (03) : 487 - 495
  • [9] Azithromycin therapy in cystic fibrosis
    Carro, LM
    Moreno, RC
    MEDICINA CLINICA, 2004, 122 (08): : 311 - 316
  • [10] Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
    Catherinot, Emilie
    Roux, Anne-Laure
    Vibet, Marie-Anne
    Bellis, Gil
    Lemonnier, Lydie
    Le Roux, Evelyne
    Bernede-Bauduin, Claire
    Le Bourgeois, Muriel
    Herrmann, Jean-Louis
    Guillemot, Didier
    Gaillard, Jean-Louis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1101 - 1106
12345